Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice.
about
Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003Minireview: Nutrient sensing by G protein-coupled receptorsPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseDevelopment of a Rapid Insulin Assay by Homogenous Time-Resolved FluorescenceOverexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine[Morphologic evaluation and Ca2+ mobilization by glicose and acetylcholine in human pancreatic cells].Muscarinic control of MIN6 pancreatic β cells is enhanced by impaired amino acid signaling.RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivoXenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.Control of insulin secretion by cholinergic signaling in the human pancreatic islet.The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.Beneficial metabolic effects caused by persistent activation of beta-cell M3 muscarinic acetylcholine receptors in transgenic mice.Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreasVagal control of pancreatic ß-cell proliferation.Hierarchical clustering of gene expression patterns in the Eomes + lineage of excitatory neurons during early neocortical developmentSecond generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications.Cathepsin L activity controls adipogenesis and glucose tolerance.Glucose homeostasis in mice is transglutaminase 2 independentAqueous fraction of Beta vulgaris ameliorates hyperglycemia in diabetic mice due to enhanced glucose stimulated insulin secretion, mediated by acetylcholine and GLP-1, and elevated glucose uptake via increased membrane bound GLUT4 transporters.Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?Sunflower Oil but Not Fish Oil Resembles Positive Effects of Virgin Olive Oil on Aged Pancreas after Life-Long Coenzyme Q Addition.Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo.Early postnatal low-protein nutrition, metabolic programming and the autonomic nervous system in adult life.CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptorsInter-organ communication and regulation of beta cell functionChronic activation of a designer G(q)-coupled receptor improves β cell function.Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesityDirect autocrine action of insulin on β-cells: does it make physiological sense?Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells.The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice.Selective expression of muscarinic acetylcholine receptor subtype M3 by mouse type III taste bud cells.Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats.
P2860
Q24633588-430E8125-B477-4BCC-99F0-9DAAC329CE27Q26864827-1AD130D7-72B7-468D-BFC6-82A5E6D59459Q27027920-CC8FAA67-A163-4842-9B3B-117EA1952C83Q27322836-516AF23E-250C-43EC-93C4-EC3D3FE8590BQ27865234-2A4ECCBA-2D93-4F20-8948-D78211394D9BQ28565154-4F1A9DDC-D329-4467-80FB-6D03AF61C722Q33286587-0EEFB1AC-F67B-4F3E-9AD0-5BD5660FD5A9Q33619580-50F6384C-0582-4F6E-BACE-504EAF1A5CB6Q33842962-C797BCC4-2D38-4DA3-AE00-9A618E3CE1D7Q33924273-FFCD4E44-595E-4A9B-A880-6871CCA6A666Q33959750-0DCCF818-4DDF-4AEE-9D11-5F6AAEA0564CQ34141128-037018CF-514B-4DB8-AEDC-E2043D395D0CQ34197823-E867C59E-B4FD-4364-89DD-8F95072706BFQ34302234-F7DDA8C1-8E5B-4D09-9BA2-B7085FB4BE3AQ34305237-787C4BDC-E83B-460C-846F-BF3249845922Q34361313-BE362281-2BD1-4A2E-B6EE-692AFDC9AF40Q34376884-57C3E4FE-B007-46E2-AE95-88096960BA13Q34397201-114F9232-1975-4266-BBA6-9B1D72852C6CQ34625376-0205DA98-697E-44B8-868E-FB5E7B1DC95AQ34654358-B0AC4FFC-E2E2-4C3F-BAF9-EEBB8F7EB37EQ34743996-91417949-9E85-4255-A91C-F3EA94391146Q35043882-4AB97EF4-4535-476B-8E28-D2EE5BD61597Q36047572-5EAFAF2D-FBCD-41F8-8A5D-9AA87EA2A296Q36053107-98058FFD-2D48-424E-829D-787819855024Q36192991-F975E9BC-5F07-416C-8AF7-1D0930D3CBCCQ36247299-CA226E77-05D9-4B0C-A4CB-297FFB341C82Q36252363-D7342B57-03BB-4539-AAEB-C7B0E42C84E3Q36295132-4758310A-B879-4A38-B0DB-CD463FB0A10EQ36371495-6F4C41D7-E9B6-4337-9258-219D19FC86E8Q36494699-82371283-7989-48D9-846E-89E3EE467177Q36599383-F1B741D4-F401-414F-9C85-AC716FA9C434Q36709997-33F98357-6B01-4BB7-AEBC-941537583A62Q36733486-D93D1C71-492A-47E6-8105-4BB07B88BDC3Q36842563-AF290D0A-9361-4517-B754-BD887336FA1EQ37014947-AF397A8E-5B2B-4369-928C-58B33D4F4118Q37050369-C5D8BF18-1CF0-4C1E-AE62-98795A8773AEQ37399121-D6DB5C06-6F0C-43FB-AAAB-12528CDD0A80Q37429180-37EEFCDF-6917-4133-BD4F-BE72314E49C4Q37475234-2080AECF-56E0-4E81-B7CA-809323BB981BQ37495641-77CAA959-3A57-46DF-AB65-F6B81DE565BC
P2860
Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@ast
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@en
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@nl
type
label
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@ast
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@en
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@nl
prefLabel
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@ast
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@en
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@nl
P2093
P1433
P1476
Muscarinic stimulation of panc ...... oline receptor-deficient mice.
@en
P2093
Alokesh Duttaroy
Charles L Zimliki
David Mears
Dinesh Gautam
Jürgen Wess
Yinghong Cui
P304
P356
10.2337/DIABETES.53.7.1714
P407
P577
2004-07-01T00:00:00Z